Literature DB >> 18698615

Hypothesis: dysregulation of methylation of brain-expressed genes on the X chromosome and autism spectrum disorders.

Julie R Jones1, Cindy Skinner, Michael J Friez, Charles E Schwartz, Roger E Stevenson.   

Abstract

The hypothesis is set forth that dysregulation of brain-expressed genes on the X chromosome constitutes the major predisposition to autism spectrum disorders (ASDs). This dysregulation, mediated by hypomethylation or hypermethylation of CpG sites within gene promoters, leads to overexpression or partial silencing of one or more brain-expressed genes, which in turn results in an unbalanced production of the proteins responsible for brain structure and function. This hypothesis accommodates the predominantly sporadic occurrence (95%), the male excess (4:1), and the usual absence of malformations or other syndromic manifestations in ASDs. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18698615     DOI: 10.1002/ajmg.a.32396

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

1.  To selectivity and beyond.

Authors:  George S Mack
Journal:  Nat Biotechnol       Date:  2010-12       Impact factor: 54.908

2.  Evidence for alterations in stimulatory G proteins and oxytocin levels in children with autism.

Authors:  Jill D Jacobson; Kathryn A Ellerbeck; Kelsie A Kelly; Kandace K Fleming; T Rene Jamison; Charles W Coffey; Catherine M Smith; R Matthew Reese; Scott A Sands
Journal:  Psychoneuroendocrinology       Date:  2013-11-26       Impact factor: 4.905

Review 3.  DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker.

Authors:  Jörg Tost
Journal:  Mol Biotechnol       Date:  2010-01       Impact factor: 2.695

Review 4.  Genomics and autism spectrum disorder.

Authors:  Norah L Johnson; Ellen Giarelli; Celine Lewis; Catherine E Rice
Journal:  J Nurs Scholarsh       Date:  2013-01-31       Impact factor: 3.176

5.  Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders.

Authors:  E S Onaivi; R Benno; T Halpern; M Mehanovic; N Schanz; C Sanders; X Yan; H Ishiguro; Q-R Liu; A L Berzal; M P Viveros; S F Ali
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

6.  Sevoflurane-induced down-regulation of hippocampal oxytocin and arginine vasopressin impairs juvenile social behavioral abilities.

Authors:  Zhi-Bin Zhou; Xiao-Yu Yang; Bao-Long Yuan; Li-Jun Niu; Xue Zhou; Wen-Qi Huang; Xia Feng; Li-Hua Zhou
Journal:  J Mol Neurosci       Date:  2014-11-25       Impact factor: 3.444

7.  Genetic and epigenetic methylation defects and implication of the ERMN gene in autism spectrum disorders.

Authors:  A Homs; M Codina-Solà; B Rodríguez-Santiago; C M Villanueva; D Monk; I Cuscó; L A Pérez-Jurado
Journal:  Transl Psychiatry       Date:  2016-07-12       Impact factor: 6.222

8.  Defective oxytocin function: a clue to understanding the cause of autism?

Authors:  Fiorella Gurrieri; Giovanni Neri
Journal:  BMC Med       Date:  2009-10-22       Impact factor: 8.775

9.  Pediatric asthma and autism-genomic perspectives.

Authors:  Sunghee Oh; Hong Ji; Drew Barzman; Ping-I Lin; John Hutton
Journal:  Clin Transl Med       Date:  2015-12-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.